Technical Analysis for AKRO - Akero Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
50 DMA Support | Bullish | -1.27% | |
Multiple of Ten Bullish | Other | -1.27% | |
Oversold Stochastic | Weakness | -1.27% | |
Crossed Above 50 DMA | Bullish | 3.64% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 3.64% | |
Pocket Pivot | Bullish Swing Setup | 3.64% | |
Inside Day | Range Contraction | 3.64% |
Alert | Time |
---|---|
Down 3% | about 18 hours ago |
Down 2 % | about 19 hours ago |
60 Minute Opening Range Breakdown | about 19 hours ago |
20 DMA Resistance | about 22 hours ago |
10 DMA Resistance | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Metabolic Disease Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Metabolic Disease Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 37.0 |
52 Week Low | 15.32 |
Average Volume | 582,134 |
200-Day Moving Average | 25.28 |
50-Day Moving Average | 29.73 |
20-Day Moving Average | 31.41 |
10-Day Moving Average | 31.48 |
Average True Range | 1.81 |
RSI (14) | 49.49 |
ADX | 25.74 |
+DI | 22.41 |
-DI | 25.42 |
Chandelier Exit (Long, 3 ATRs) | 30.43 |
Chandelier Exit (Short, 3 ATRs) | 32.49 |
Upper Bollinger Bands | 35.31 |
Lower Bollinger Band | 27.51 |
Percent B (%b) | 0.4 |
BandWidth | 24.85 |
MACD Line | 0.18 |
MACD Signal Line | 0.59 |
MACD Histogram | -0.4133 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 33.22 | ||||
Resistance 3 (R3) | 33.26 | 32.43 | 32.79 | ||
Resistance 2 (R2) | 32.43 | 31.77 | 32.41 | 32.65 | |
Resistance 1 (R1) | 31.53 | 31.36 | 31.12 | 31.50 | 32.50 |
Pivot Point | 30.70 | 30.70 | 30.50 | 30.69 | 30.70 |
Support 1 (S1) | 29.81 | 30.04 | 29.39 | 29.77 | 28.77 |
Support 2 (S2) | 28.98 | 29.64 | 28.96 | 28.62 | |
Support 3 (S3) | 28.08 | 28.98 | 28.48 | ||
Support 4 (S4) | 28.05 |